Clinical trials: PET Positive
Breast Cancer
18F-FES PET/CT in the Treatment Planning, and Response Assessment of ER-Positive Breast Cancer
This study uses FES PET/CT imaging to evaluate estrogen receptor-positive breast cancer. FES PET/CT is a type of imaging that can show whether breast cancer cells have estrogen receptors.
- Trial name
- NCT07859046
- Where
- China
- Volunteers
- 100 people
- Sponsor
- Hunan Cancer Hospital